Search by Drug Name or NDC

    NDC 71399-1006-06 Adult Tussin Cough and Chest Congestion DM Sugar Free 20; 200 mg/10mL; mg/10mL Details

    Adult Tussin Cough and Chest Congestion DM Sugar Free 20; 200 mg/10mL; mg/10mL

    Adult Tussin Cough and Chest Congestion DM Sugar Free is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by Akron Pharma Inc.. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN.

    Product Information

    NDC 71399-1006
    Product ID 71399-1006_98c8f525-56fd-4c53-be3b-e7ffd0e13d2c
    Associated GPIs
    GCN Sequence Number 000652
    GCN Sequence Number Description guaifenesin/dextromethorphan LIQUID 100-10MG/5 ORAL
    HIC3 B3T
    HIC3 Description NON-OPIOID ANTITUSSIVE AND EXPECTORANT COMBINATION
    GCN 53491
    HICL Sequence Number 000223
    HICL Sequence Number Description GUAIFENESIN/DEXTROMETHORPHAN HBR
    Brand/Generic Generic
    Proprietary Name Adult Tussin Cough and Chest Congestion DM Sugar Free
    Proprietary Name Suffix n/a
    Non-Proprietary Name Dextromethorphan HBr, Guaifenesin
    Product Type HUMAN OTC DRUG
    Dosage Form LIQUID
    Route ORAL
    Active Ingredient Strength 20; 200
    Active Ingredient Units mg/10mL; mg/10mL
    Substance Name DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN
    Labeler Name Akron Pharma Inc.
    Pharmaceutical Class Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Ant
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2023-12-31

    Package

    NDC 71399-1006-06 (71399100606)

    NDC Package Code 71399-1006-6
    Billing NDC 71399100606
    Package 473 mL in 1 BOTTLE, PLASTIC (71399-1006-6)
    Marketing Start Date 2022-11-11
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 1505298a-528f-4f94-b926-1e78d0b3f58e Details

    Revised: 11/2022